New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011–2021) focussing on structure–activity relationship (SAR) and docking insights
2021 ◽
Vol 36
(1)
◽
pp. 1574-1602
2000 ◽
Vol 40
(4)
◽
pp. 994-1001
◽
2011 ◽
Vol 12
(9)
◽
pp. 6104-6115
◽
2008 ◽
Vol 43
(7)
◽
pp. 1376-1389
◽
2005 ◽
Vol 13
(5)
◽
pp. 1749-1761
◽
1997 ◽
Vol 10
(3)
◽
pp. 173-180
◽
2019 ◽
Vol 11
(22)
◽
pp. 2919-2973
◽